Circulating cytochrome c as potential biomarker of impaired reperfusion in ST-segment elevation acute myocardial infarction.

[1]  Michael Weis,et al.  [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. , 2009, Giornale italiano di cardiologia.

[2]  D. Yellon,et al.  The mitochondrial permeability transition pore as a target for preconditioning and postconditioning , 2009, Basic Research in Cardiology.

[3]  Frans Van de Werf,et al.  MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION (ENDING) , 2009 .

[4]  Michael Weis,et al.  Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. , 2008, European heart journal.

[5]  Pierre Croisille,et al.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.

[6]  Tak W. Mak,et al.  Cytochrome c: functions beyond respiration , 2008, Nature Reviews Molecular Cell Biology.

[7]  J. Ottervanger,et al.  Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. , 2008, American heart journal.

[8]  R. Gottlieb,et al.  Heart mitochondria: gates of life and death. , 2008, Cardiovascular research.

[9]  G. Derumeaux,et al.  Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[10]  R. Gazmuri,et al.  Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival. , 2007, American journal of physiology. Heart and circulatory physiology.

[11]  P. Bernardi,et al.  Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. , 2006, Cardiovascular research.

[12]  L. Argaud,et al.  Mitochondrial permeability transition pore and postconditioning. , 2006, Cardiovascular research.

[13]  J. Boura,et al.  Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials , 2006, The Lancet.

[14]  L. Argaud,et al.  Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury. , 2005, Journal of molecular and cellular cardiology.

[15]  M. Kreuter,et al.  Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy , 2005, International journal of cancer.

[16]  B. Gersh,et al.  Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. , 2005, European heart journal.

[17]  R. Zager,et al.  Proximal tubular cytochrome c efflux: determinant, and potential marker, of mitochondrial injury. , 2004, Kidney international.

[18]  Peipei Ping,et al.  Role of the mitochondrial permeability transition in myocardial disease. , 2003, Circulation research.

[19]  E. Antman,et al.  ESC COMMITTEE FOR PRACTICE GUIDELINES MEMBERS , 2003 .

[20]  S. de Servi,et al.  Integrated Analysis of Myocardial Blush and ST-Segment Elevation Recovery After Successful Primary Angioplasty: Real-Time Grading of Microvascular Reperfusion and Prediction of Early and Late Recovery of Left Ventricular Function , 2002, Circulation.

[21]  D. Yellon,et al.  Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? , 2002, Cardiovascular research.

[22]  S. Chierchia,et al.  Influence of treatment delay on long-term left ventricular function in patients with acute myocardial infarction successfully treated with primary angioplasty. , 2001, American heart journal.

[23]  M J Davies,et al.  The pathophysiology of acute coronary syndromes , 2000, Heart.

[24]  H. Suryapranata,et al.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. , 1998, Circulation.

[25]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[26]  L. Mogensen,et al.  Serum CK-MB kinetics in acute myocardial infarction and after coronary bypass operations. , 1979, Scandinavian journal of thoracic and cardiovascular surgery.